International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Downloads: 110 | Views: 199 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Review Papers | Biomedical Sciences | India | Volume 9 Issue 7, July 2020

Polycystic Ovary Syndrome (PCOS) Symptoms, Causes & Treatments - A Review

Nobendu Mukerjee [2]

Abstract: Polycystic ovary syndrome [PCOS] is the most common endocrinopathy of women in reproductive age. An association between PCOS and type-1 endometrial cancer has often been reported in the literature. The prolonged anovulation with consequent continued secretion of estrogen unopposed by progesterone may enhance the development and growth of this malignancy, particularly in young women. Hypersecretion of luteinizing hormone [LH], chronic hyperinsulinemia and increased serum insulin-like growth factor [IGF] levels may represent risk factors for endometrial cancer. However, data available in the literature do not allow a meta-analysis to be carried out to calculate an estimate of the relative risk of endometrial cancer in women with PCOS. Anecdotal cases of low-grade endometrial stromal sarcoma and carcinosarcoma have been reported in association with prolonged unopposed estrogen stimulation, and in particular with PCOS. A few studies have addressed the possibility of an association between PCOS and epithelial ovarian cancer risk. Women with PCOS produce higher-than-normal amounts of male hormones. This hormone imbalance causes them to skip menstrual periods and makes it harder for them to get pregnant.

Keywords: androgenetic alopecia, cyproterone acetate, drospirenone, polycystic ovary syndrome, spironolactone, MAPK/ERK/p38 signaling pathway, metformin, clomiphene citrate, clomiphene citrate resis

Edition: Volume 9 Issue 7, July 2020,

Pages: 1949 - 1957

How to Download this Article?

Type Your Valid Email Address below to Receive the Article PDF Link

Verification Code will appear in 2 Seconds ... Wait